01月28日
6th RNAi-based therapeutics summit
1.28 - 1.30
Boston, MA, USA
Hongene is thrilled to announce our participation in 6th RNAi-based therapeutics summit. As innovative drug delivery platforms beyond GalNAc continued to emerge and novel chemical modifications were discovered, the potential for RNAi therapeutics to treat a plethora of diseases grew. More than ever, RNAi therapies held promise to treat diseases beyond the liver and provide efficacious, tolerable treatment options for patients.
The 6th RNAi-Based Therapeutics Summit returned to Boston to showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools that assisted payload design, and breakthrough chemical modifications which enhance stability, allowing for precise therapeutic delivery.
Uniting 70+ leaders of the RNAi world, this Summit empowered experts to pioneer their RNAi candidates into clinically successful therapies. Bringing together technical and strategic experts from Novo Nordisk, Alynlam Therapeutics, Judo Bio, Aro Biotherapeutics, Novartis, Comanche Biopharma and more, this meeting was a unique gathering of RNAi's sharpest minds, dedicated to progressing the next wave of RNAi therapeutics to improve healthcare for patients in need.
Welcome to visit our booth. Let's discuss how Hongene's high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.